2-47803500-AC-ACCC
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000179.3(MSH6):c.3260_3261dupCC(p.Phe1088ProfsTer3) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000179.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Lynch syndrome 5 Pathogenic:1
This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.3260_3261dupCC pathogenic mutation, located in coding exon 5 of the MSH6 gene, results from a duplication of 2 nucleotides at positions 3260 to 3261, causing a translational frameshift with a predicted alternate stop codon (p.F1088Pfs*3). This mutation has been detected as somatic in multiple colorectal cancer patients and cell lines (Bonk T et al. Clin Chem. 2003 Apr;49(4):552-61; Weiss MB et al. Cancer Gene Ther. 2007 Jan;14(1):98-104; Berginc G et al. Fam. Cancer 2009 Jun;8(4):421-9; McCarthy AJ et al. J Pathol Clin Res. 2018 Nov 1). Of note, this alteration is designated as c.3260_3261insCC in published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at